Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells

Cancer Gene Therapy
Bahri KaracayDaniel J Bonthius

Abstract

Neuroblastoma is the most common solid extracranial neoplasm in children and causes many deaths. Despite treatment advances, prognosis for neuroblastoma remains poor, and a critical need exists for the development of new treatment regimens. TNF-related apoptosis-inducing-ligand (TRAIL) induces cell death in a variety of tumors, but not in normal tissues. Moreover, TRAIL is nontoxic, making it a strong antitumor therapeutic candidate. We demonstrate that introduction of the TRAIL gene into neuroblastoma cell lines using an adenoviral vector leads to apoptotic cell death. RT-PCR and flow-cytometric analyses demonstrated that TRAIL's effect is mediated primarily via the TRAIL R2 receptor. As TRAIL can activate the nuclear factor-kappaB (NF-kappaB) signaling pathway, which can exert an antiapoptotic effect, we hypothesized that inhibition of NF-kappaB signaling may augment TRAIL's killing effects. TRAIL-mediated cell death was enhanced when neuroblastoma cells were simultaneously infected with a dominant-negative mutant of IkappaB kinase, a kinase essential for NF-kappaB activation. The combination of blockade of NF-kappaB signaling and expression of TRAIL induced apoptotic death in a greater proportion of SKNSH cells than did eith...Continue Reading

References

Mar 30, 1984·Journal of Immunological Methods·D A Flick, G E Gifford
Jan 1, 1995·World Journal of Urology·T Humpl
Nov 1, 1996·Science·D J Van AntwerpI M Verma
Jul 15, 1997·Frontiers in Bioscience : a Journal and Virtual Library·G McGill, D E Fisher
Jan 7, 1998·Experimental Cell Research·J L HerrmannT J McDonnell
Aug 28, 1998·Science·A Ashkenazi, V M Dixit
Oct 31, 1998·Current Opinion in Immunology·T S Griffith, D H Lynch
Feb 4, 1999·Nature Medicine·L E French, J Tschopp
Apr 21, 1999·Current Opinion in Cell Biology·A Ashkenazi, V M Dixit
Dec 22, 1999·Oncogene·B Rayet, C Gélinas
Mar 21, 2000·Biochimica Et Biophysica Acta·M W Mayo, A S Baldwin
Apr 29, 2000·Nature·K M RyanK H Vousden
Aug 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·T S GriffithT L Ratliff
Feb 24, 2001·Annals of the New York Academy of Sciences·K AbeR Khosravi-Far
Sep 8, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·T S Griffith, E L Broghammer
Feb 8, 2002·Cell·Ricky W JohnstoneScott W Lowe
Mar 22, 2002·Nature Reviews. Cancer·P Hersey, X D Zhang
Aug 29, 2002·The Journal of Biological Chemistry·Xin BianValerie P Castle

❮ Previous
Next ❯

Citations

Feb 22, 2008·Journal of the American Society of Nephrology : JASN·Corina LorzAlberto Ortiz
Jun 24, 2009·Journal of Oncology·Lyse A NorianThomas S Griffith
Aug 24, 2016·Cell Death Discovery·P RuggeriA R Mackay
Jun 28, 2011·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Sangeetha Sukumari-RameshKrishnan M Dhandapani
May 22, 2007·International Journal of Radiation Oncology, Biology, Physics·Ahter D SanliogluSalih Sanlioglu
Sep 8, 2015·Pharmacology & Therapeutics·Gustavo P Amarante-Mendes, Thomas S Griffith
Mar 27, 2015·Head & Neck·Evren ErkulHakan Cincik
May 31, 2018·Anti-cancer Drugs·Andrey V UgolkovAndrew P Mazar
Sep 17, 2005·American Journal of Physiology. Gastrointestinal and Liver Physiology·Norihisa IshimuraGregory J Gores
Dec 10, 2016·Cancer Metastasis Reviews·Bora Lim, Gabriel N Hortobagyi
Nov 21, 2020·The FEBS Journal·Ludmila Cardoso AlvesPhilippe Krebs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.